- [[#Epinephrine]]
	- [[#Epinephrine#MOA|MOA]]
- [[#α2 agonists]]
	- [[#α2 agonists#MOA|MOA]]
	- [[#α2 agonists#Apraclonidine:|Apraclonidine:]]
	- [[#α2 agonists#Brimonidine:|Brimonidine:]]
- [[#Beta blockers|Beta blockers]]
- [[#Carbonic anhydrase inhibitors 局部碳酸酐酶抑制劑|Carbonic anhydrase inhibitors 局部碳酸酐酶抑制劑]]
	- [[#Carbonic anhydrase inhibitors 局部碳酸酐酶抑制劑#Systemic CA inhibitors:|Systemic CA inhibitors:]]
	- [[#Carbonic anhydrase inhibitors 局部碳酸酐酶抑制劑#Topical CA inhibitors:|Topical CA inhibitors:]]
	- [[#Carbonic anhydrase inhibitors 局部碳酸酐酶抑制劑#MOA|MOA]]
- [[#Prostaglandin analogues 前列腺素衍生物|Prostaglandin analogues 前列腺素衍生物]]
	- [[#Prostaglandin analogues 前列腺素衍生物#MOA|MOA]]
	- [[#Prostaglandin analogues 前列腺素衍生物#Latanoprost:|Latanoprost:]]
	- [[#Prostaglandin analogues 前列腺素衍生物#Unoprostone:|Unoprostone:]]
	- [[#Prostaglandin analogues 前列腺素衍生物#Bimatoprost:|Bimatoprost:]]
	- [[#Prostaglandin analogues 前列腺素衍生物#Travaprost :|Travaprost :]]

---
## [[Epinephrine]] 
- Directly acting sympathomimetic
### MOA
- Reduced aqueous production due to $\alpha$ action 
- trabecular outflow via $\beta$ receptor stimulation
###
-  Due to its CVS s/e , allergic reaction – no longer used
- Is a prodrug
	 - ==Dipivefrin==
	- Formed by di-esterification of epinephrine – lipophilicity– increased penetration to anterior chamber .
## [[α2 agonists]] 
### MOA
- Decrease aqueous humour production by $\alpha_{2}$ action on ciliary epithelium.
### Apraclonidine:

^9cbde8

- Also known as para amino clonidine
- Short term use – Post op rise in IOP
### Brimonidine:

^b9266d

- 30 times more selective α<sub>2</sub> agonist than apraclonidine
- Additional neuroprotective effect
- Uses:
	- in patients with contraindications to beta blockers,
	- short term use in post op raise in IOP
## Beta blockers
- Considered to be 1st line therapy for all types of glaucoma
- Good efficacy , Minimal S/E
- MOA: 
	- Decreases aqueous humour production by blocking $\beta_{2}$ receptors on ciliary epithelium.
- Timolol ^f3e73c
	- Most widely used ocular hypotensive agent 
	- Due to its non selective beta action 
		- cautious in COPD, asthma & heart failure
- Carteolol: 
	- Levobunolol
- Betaxolol  ^1c9c50
	- Introduced in 1980s as 1st topical β<sub>1</sub> blocker used in glaucoma 
	- Clinical trials 
		- lesser efficacy in reducing IOP compared to timolol
		- Additional neuroprotective effect.
## Carbonic anhydrase inhibitors 局部碳酸酐酶抑制劑
### Systemic CA inhibitors:
- Acetazolamide,
- Methazolamide
- Dichlorphenamide
### Topical CA inhibitors:
- Dorzolamide
- Brinzolamide
### MOA
- Blocks CA enzyme reversibly in ciliary body 
	- reduces aqueous humour production
## Prostaglandin analogues 前列腺素衍生物
- Includes latanoprost, unoprostone, bimatoprost, travoprost.
### MOA
- Decreases IOP by increasing uveoscleral outflow 葡萄膜鞏膜通路
### Latanoprost:
- Introduced in 1996 
- An ester prodrug analogue of PGF2α
### Unoprostone:
- Additional neuroprotective effect  
	- increasing microcirculation in optic nerve head
### Bimatoprost: 
- A synthetic prostamide analogue 
- Does not require refrigeration 
### Travaprost :
- Synthetic PGF2α analogue
- Does not require refrigeration/ protection from sunlight